NexMed, Inc., an emerging international pharmaceutical and medical device company, is developing 1)
Alprox-TD and Femprox, topically-applied treatments for male and female sexual dysfunction; and 2) Viratrol, a non-invasive, hand-held device for treating oral and genital herpes.